Qasim Chaudhry
Transplant Surgery · Des Moines, IANPI 1821252750
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (44.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 49.6% of the total. Reporting peaked in 2020 at $8,021 and has fallen 99.7% since, to $21 in 2025.
Across 54 payments — averaging $231.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$6K
- Intuitive Surgical$4K
- Transmedics, Inc.$2K
- AbbVie$87
- Merck$39
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$30
- plus $57 from 3 others
Across 26 payments — averaging $83.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- CSL Behring$2K
What the payments were for
- Speaking & faculty fees$5,40043%
- Travel & lodging$5,54144%
- Food & beverage$1,52212%
- Education$40%
- Gifts$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 11 | $6,187 |
| Intuitive Surgical | 29 | $3,715 |
| Transmedics, Inc. | 3 | $2,359 |
| AbbVie | 4 | $87 |
| Merck | 2 | $39 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $30 |
| Medtronic | 1 | $25 |
| Davol Inc. | 1 | $17 |
| Novartis | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NULOJIX$6,025
- Da Vinci Surgical System$3,000
- ORGAN CARE SYSTEM$2,359
How this compares
Too few transplant surgery providers in Iowato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Valganciclovir Hcl | 127 | $15,121 |
| Mycophenolic AcidMycophenolate Sodium | 27 | $12,200 |
| Tacrolimus | 24 | $6,407 |
| Enoxaparin Sodium | 62 | $3,513 |
| Rosuvastatin Calcium | 72 | $1,865 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 228 | $1,575 |
| Nystatin | 49 | $1,176 |
| Famotidine | 195 | $1,053 |
| Prednisone | 193 | $955 |
| Bumetanide | 32 | $842 |
| Amlodipine Besylate | 136 | $523 |
| Carvedilol | 101 | $505 |
| Nifedipine ErNifedipine | 14 | $486 |
| Hydralazine Hcl | 39 | $445 |
| Cinacalcet Hcl | 16 | $442 |
Paid to pharmacies, not to this prescriber.
Other transplant surgery in Des Moines
- Juan ArenasDes Moines$5K
- Mohammad AlzghariDes Moines$3K
- David AxelrodIowa City$65K
- Hassan AzizIowa City$10K
- Ramy El-DiwanyIowa City$4K
- Alan HemmingIowa City$63
- Alan ReedIowa City$63
- Daniel KatzIowa City$25
- Muhammad AbbasCoralville$25
- Shengliang HeIowa City$21
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.